n-methylaminoethanol has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, M; Inoue, S; Mano, T; Masuyama, T; Miwa, T; Nishikawa, N; Oishi, Y; Sakata, Y; Takahashi, Y; Yamamoto, K; Yoshida, J | 1 |
1 other study(ies) available for n-methylaminoethanol and Cirrhosis
| Article | Year |
|---|---|
N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism.
Topics: Animals; Blood Pressure; Collagen; Collagenases; Enzyme Inhibitors; Ethanolamines; Fibroblasts; Fibrosis; Heart Ventricles; Male; Phospholipase D; Rats; Rats, Inbred Dahl; Ventricular Dysfunction | 2004 |